NEW YORK (GenomeWeb News) – Epigenomics and Wuhan Kindstar Clinical Diagnostics today announced a licensing and supply deal for the Epi proLung tissue assay for the Chinese market.

The terms of the deal call for Kindstar to commercialize Epigenomics' assay, while the Berlin-based company will manufacture and supply it. Epigenomics also will provide support "with respect to medical and regulatory considerations."

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.